Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.

Twiss J, McKenna S, Ganderton L, Jenkins S, Ben-L'amri M, Gain K, Fowler R, Gabbay E.

BMC Pulm Med. 2013 Jul 12;13:45. doi: 10.1186/1471-2466-13-45.

2.

Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.

Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E.

Respirology. 2011 Nov;16(8):1235-40. doi: 10.1111/j.1440-1843.2011.02030.x.

PMID:
21810146
3.

Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial.

Ganderton L, Jenkins S, Gain K, Fowler R, Winship P, Lunt D, Gabbay E.

BMC Pulm Med. 2011 May 23;11:25. doi: 10.1186/1471-2466-11-25.

4.

Proteus mirabilis biofilms and the encrustation of urethral catheters.

Stickler D, Ganderton L, King J, Nettleton J, Winters C.

Urol Res. 1993;21(6):407-11.

PMID:
8171763
5.

Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters.

Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D.

Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):789-96.

PMID:
1468417
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk